本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ARS PHARMACEUTICALS INC

4.76
-0.3000-5.93%
盤後4.890.1300+2.73%19:43 EDT
成交量:257.35萬
成交額:1,257.38萬
市值:4.73億
市盈率:-2.19
高:5.19
開:5.13
低:4.73
收:5.06
52周最高:13.15
52周最低:4.73
股本:9,944.73萬
流通股本:4,803.45萬
量比:2.58
換手率:5.36%
股息:- -
股息率:- -
每股收益(TTM):-2.1757
每股收益(LYR):-1.7400
淨資產收益率:-210.35%
總資產收益率:-48.02%
市淨率:37.83
市盈率(LYR):-2.74

資料載入中...

2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/17

重要事件披露

Form 8-K - Current report
2026/07/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/07

重要事件披露

Form 8-K - Current report
2026/06/25

重要事件披露

Form 8-K - Current report